Form 4 holding
Director
TScan Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 67,027
- Estimated value
- $333,024
- Report date
- 19 Dec 2023
- Price
- $4.97
- Ownership
- Direct
Timothy J. Barberich
Insider Reports History
- Reporting-owner location
- Concord, MA
- Latest reporting-owner signature
-
/s/ Timothy Barberich
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Timothy J. Barberich
Form 4 holding
Director
TScan Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 33,259
- Estimated value
- $165,247
- Report date
- 18 Dec 2023
- Price
- $4.97
- Ownership
- By Barberich Family Trust
Form 4 holding
Director
TScan Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 35,000
- Estimated value
- Report date
- 13 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount
Form 4 holding
Director
Verastem, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 25,000
- Estimated value
- Report date
- 28 Jun 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Frequency Therapeutics, Inc.
- Security class
- Stock Option
- Shares / value
- 0
- Estimated value
- Report date
- 17 Aug 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Timothy J. Barberich
4
TCRX
TScan Therapeutics, Inc.
- Report period
- 18 Dec 2023
- Transactions
- 2
- Transaction value
- +$142,456
- Accepted by SEC
- 21 Dec 2023, 17:00
- Role
- Director
- Next action
- Open filing details
4
TCRX
TScan Therapeutics, Inc.
- Report period
- 13 Jun 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 Jun 2023, 18:25
- Role
- Director
- Next action
- Open filing details
4
TCRX
TScan Therapeutics, Inc.
- Report period
- 02 Jun 2023
- Transactions
- 1
- Transaction value
- +$99,564
- Accepted by SEC
- 06 Jun 2023, 19:53
- Role
- Director
- Next action
- Open filing details
4
KRRO
Frequency Therapeutics, Inc.
- Report period
- 17 Aug 2022
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 19 Aug 2022, 16:09
- Role
- Director
- Next action
- Open filing details
4
KRRO
Frequency Therapeutics, Inc.
- Report period
- 21 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Jun 2022, 16:15
- Role
- Director
- Next action
- Open filing details
4
TCRX
TScan Therapeutics, Inc.
- Report period
- 01 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 Jun 2022, 16:30
- Role
- Director
- Next action
- Open filing details
4
TCRX
TScan Therapeutics, Inc.
- Report period
- 20 Jul 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 22 Jul 2021, 07:43
- Role
- Director
- Next action
- Open filing details
3
TCRX
TScan Therapeutics, Inc.
- Report period
- 15 Jul 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 15 Jul 2021, 18:21
- Role
- Director
- Next action
- Open filing details
4
VSTM
Verastem, Inc.
- Report period
- 28 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 30 Jun 2021, 13:57
- Role
- Director
- Next action
- Open filing details
4
KRRO
Frequency Therapeutics, Inc.
- Report period
- 17 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 21 Jun 2021, 16:27
- Role
- Director
- Next action
- Open filing details